Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-26

Clinical Trial Update: Multicenter Retrospective Study of Isoflurane in Refractory and Super-Refractory Status Epilepticus

View source ↗

Summary

A multicenter retrospective study assessing isoflurane for refractory and super-refractory status epilepticus; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • isoflurane (isoflurane)

Snippet

Sponsor: Hopital of Melun | Conditions: Refractory Status Epilepticus | Status: COMPLETED